NRXP icon

NRX Pharmaceuticals

15 hedge funds and large institutions have $32.4M invested in NRX Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
OAM
1
Oxford Asset Management
United Kingdom
$5.64M 533,072 -25,000 -4%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$5.48M 517,500
MF
3
Magnetar Financial
Illinois
$4.89M 465,000 +465,000 New
MSU
4
Mizuho Securities USA
New York
$3.21M 303,056 -334,214 -52%
WCMNY
5
Westchester Capital Management (New York)
New York
$2.59M 244,658
WAM
6
Weiss Asset Management
Massachusetts
$2.59M 244,436 -338,870 -58%
AA
7
AQR Arbitrage
Connecticut
$2.09M 200,000
KPF
8
K2 Principal Fund
Ontario, Canada
$2.04M 193,091
YCM
9
Yakira Capital Management
Connecticut
$1.75M 165,000
BFM
10
Boothbay Fund Management
New York
$1.06M 100,000 -200,000 -67%
VOAM
11
Vertex One Asset Management
British Columbia, Canada
$1.06M 100,000 +100,000 New
BCM
12
Bluefin Capital Management
New York
$17K 101,600
UBS Group
13
UBS Group
Switzerland
$16K 1,529 -1,737 -53%
Carson Wealth (CWM LLC)
14
Carson Wealth (CWM LLC)
Nebraska
$4K 320
RCM
15
Rivernorth Capital Management
Florida
$2.54K 239,998
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
-375,000 Closed
BCM
17
Basso Capital Management
Connecticut
-100,000 Closed
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
-11,471 Closed
CL
19
CSS LLC
Illinois
-2,926 Closed
CFGS
20
Concourse Financial Group Securities
Alabama